Related Experiment Video
Updated: May 27, 2025

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena.
Aamir Bashir1, Ajay Duseja2, Arka De2
1Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Mohali, Punjab, India.
Non-alcoholic fatty liver disease (NAFLD) involves excess liver fat, often linked to metabolic syndrome. This review explores its complex causes, aiming to guide new NAFLD treatments.
Area of Science:
- Hepatology
- Metabolic Disorders
- Lipid Metabolism
Background:
- Non-alcoholic fatty liver disease (NAFLD) is a prevalent metabolic disorder characterized by excessive intrahepatic fat accumulation.
- It is considered the hepatic manifestation of metabolic syndrome (MS), though it can affect non-obese individuals without MS components.
- NAFLD pathogenesis is multifactorial, involving genetic, environmental, and metabolic factors, with ongoing discoveries in pathogenic phenomena.
Purpose of the Study:
- To review and elucidate the diverse pathogenic mechanisms underlying NAFLD development and progression.
- To provide a comprehensive understanding of the interplay between various factors contributing to fatty liver.
- To identify potential avenues for novel therapeutic strategies for NAFLD patients.
Main Methods:
- Comprehensive literature review of existing studies on NAFLD pathogenesis.
- Analysis of genetic, environmental, and metabolic factors influencing lipid homeostasis in the liver.
- Synthesis of current knowledge on the multifactorial nature of NAFLD progression.
Main Results:
- NAFLD results from an imbalance in hepatic lipid uptake, synthesis, and metabolism.
- Both genetic predisposition and environmental influences play significant roles in NAFLD development.
- The progression mechanisms of NAFLD are complex and not yet fully understood, involving multiple interacting pathways.
Conclusions:
- Understanding the intricate pathogenic mechanisms of NAFLD is crucial for developing effective treatments.
- Further research into the interplay of genetic and environmental factors is needed to fully unravel NAFLD progression.
- Elaborating on NAFLD pathogenesis can pave the way for targeted therapies and improved patient outcomes.
More Related Videos
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Inflammation
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...